pyrroles has been researched along with Lymphoma, T-Cell, Cutaneous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonefeld, CM; Fredholm, S; Geisler, C; Gniadecki, R; Iversen, L; Jønson, L; Kopp, KL; Krejsgaard, T; Lindahl, LM; Litvinov, IV; Mongan, NP; Nastasi, C; Odum, N; Petersen, DL; Sasseville, D; Sibbesen, NA; Wasik, MA; Willerslev-Olsen, A; Woetmann, A | 1 |
1 other study(ies) available for pyrroles and Lymphoma, T-Cell, Cutaneous
Article | Year |
---|---|
Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
Topics: Cell Line, Tumor; Genes, Tumor Suppressor; Humans; Janus Kinase 3; Lymphoma, T-Cell, Cutaneous; MicroRNAs; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Signal Transduction; Skin Neoplasms; STAT3 Transcription Factor; STAT5 Transcription Factor; Transfection | 2015 |